Details
Stereochemistry | RACEMIC |
Molecular Formula | C18H26O3 |
Molecular Weight | 290.3972 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1
InChI
InChIKey=YBGZDTIWKVFICR-JLHYYAGUSA-N
InChI=1S/C18H26O3/c1-4-6-7-15(5-2)14-21-18(19)13-10-16-8-11-17(20-3)12-9-16/h8-13,15H,4-7,14H2,1-3H3/b13-10+
Molecular Formula | C18H26O3 |
Molecular Weight | 290.3972 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 1 |
Optical Activity | ( + / - ) |
Octinoxate, also called Octyl methoxycinnamate or (OMC), is a UV filter. It can be absorbed rapidly through skin.Octinoxate filters UV‐B rays from the sun, although it does not protect against UV-A rays. Octinoxate dissolves in oil, which makes it a fat-seeking substance in the body. It is formed by combining methoxycinnamic acid and 2-ethylhexanol compounds which are not harmful on their own. When mixed together, they form a clear liquid that does not dissolve in water. Octinoxate is found in hair color products and shampoos, sunscreen, lipstick, nail polish, and skin creams. In products other than sunscreens, it is used as a UV filter to protect the products from degrading when exposed to the sun.
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Octyl methoxycinnamate modulates gene expression and prevents cyclobutane pyrimidine dimer formation but not oxidative DNA damage in UV-exposed human cell lines. | 2010 Apr |
|
Mixtures of environmentally relevant endocrine disrupting chemicals affect mammary gland development in female and male rats. | 2015 Jul |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:20:24 GMT 2023
by
admin
on
Fri Dec 15 16:20:24 GMT 2023
|
Record UNII |
4Y5P7MUD51
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
CFR |
21 CFR 352.20
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
||
|
WHO-ATC |
D02BA02
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
||
|
FDA ORPHAN DRUG |
142401
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
||
|
CFR |
21 CFR 352.10
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
||
|
WHO-VATC |
QD02BA02
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
||
|
NCI_THESAURUS |
C851
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
||
|
EPA PESTICIDE CODE |
88407
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
26466
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
SUB20704
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
13369
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | RxNorm | ||
|
OCTYL METHOXYCINNAMATE
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
4236
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
DTXSID9047205
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
52441-07-3
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
NO STRUCTURE GIVEN | |||
|
4Y5P7MUD51
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
5355130
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
226-775-7
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
CHEMBL1200608
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
1477900
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
C66252
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
LL-25
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
100000091481
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
m8129
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB09496
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
5466-77-3
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
4Y5P7MUD51
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
5466-77-3
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
7945
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY | |||
|
83834-59-7
Created by
admin on Fri Dec 15 16:20:24 GMT 2023 , Edited by admin on Fri Dec 15 16:20:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ENANTIOMER -> RACEMATE | |||
|
ENANTIOMER -> RACEMATE | |||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |